Concurrent treatment for substance use disorder and trauma-related comorbidities a review of clinical effectiveness and guidelines
The purpose of this report is to review treatment options for patients with comorbid substance use disorder (SUD) and post-traumatic stress disorder, anxiety, or depression by comparing (1) concurrent treatments for SUD and the mental disorders with no treatment, usual care or active treatment for o...
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
August 16, 2017, 2017
|
| Edition: | Version: 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The purpose of this report is to review treatment options for patients with comorbid substance use disorder (SUD) and post-traumatic stress disorder, anxiety, or depression by comparing (1) concurrent treatments for SUD and the mental disorders with no treatment, usual care or active treatment for one condition only and (2) treatment for a single condition (SUD or the mental disorders) with no treatment, usual care or active treatment for the second disorder. Additionally, this review aims to review evidence-based guidelines regarding the treatments for patients with these comorbidities |
|---|---|
| Physical Description: | 1 PDF file (42 pages) illustrations |